1.43
                                            Precedente Chiudi:
              $1.44
            Aprire:
              $1.5
            Volume 24 ore:
                5.71M
            Relative Volume:
              1.40
            Capitalizzazione di mercato:
                $233.06M
            Reddito:
              -
            Utile/perdita netta:
              $-111.13M
            Rapporto P/E:
              -1.0833
            EPS:
                -1.32
            Flusso di cassa netto:
                $-91.53M
            1 W Prestazione:
              -13.86%
            1M Prestazione:
              -11.73%
            6M Prestazione:
                +175.00%
            1 anno Prestazione:
              -26.29%
            Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
                  
                      Tenaya Therapeutics Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      415-865-2066
                    
                Indirizzo
                  
                      171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
                    
                Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                TNYA
                            
                             
                        Tenaya Therapeutics Inc 
                           | 
                    1.43 | 234.69M | 0 | -111.13M | -91.53M | -1.32 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform | 
| 2023-11-30 | Iniziato | Leerink Partners | Outperform | 
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy | 
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
How resilient is Tenaya Therapeutics Inc. stock in market downturnsQuarterly Growth Report & Long-Term Capital Growth Ideas - newser.com
Is Tenaya Therapeutics Inc. stock positioned well for digital economyPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
Trend analysis for Tenaya Therapeutics Inc. this week2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
Tenaya Therapeutics Inc. stock chart pattern explainedJuly 2025 Trends & AI Based Buy/Sell Signal Reports - newser.com
Is Tenaya Therapeutics Inc. stock undervalued vs historical averages2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
What analysts say about Tenaya Therapeutics Inc stockCovered Call Writing & Advanced Stock Screening Tools - earlytimes.in
Will Tenaya Therapeutics Inc. stock attract ESG investorsEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Will Tenaya Therapeutics Inc. stock gain from lower inflationInflation Watch & Low Drawdown Investment Ideas - newser.com
When is the best time to exit Tenaya Therapeutics Inc.Weekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.Weekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
Statistical indicators supporting Tenaya Therapeutics Inc.’s strengthWeekly Profit Summary & Consistent Return Investment Signals - newser.com
How to escape a deep drawdown in Tenaya Therapeutics Inc.2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com
Can Tenaya Therapeutics Inc. rally from current levelsJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Can Tenaya Therapeutics Inc. stock rebound after recent weaknessWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Will Tenaya Therapeutics Inc. stock continue dividend increasesIndex Update & AI Driven Stock Movement Reports - newser.com
Tenaya Therapeutics (TNYA) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Tenaya Therapeutics Advances Pediatric Cardiomyopathy Research with New Study Update - TipRanks
Can you recover from losses in Tenaya Therapeutics Inc.Entry Point & Safe Entry Momentum Stock Tips - newser.com
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):